{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:21:12Z","timestamp":1793906472918,"version":"4.8.0"},"reference-count":80,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,6,12]]},"DOI":"10.1080\/14656566.2024.2370895","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T16:22:40Z","timestamp":1718814160000},"page":"1163-1174","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Treating influenza with neuraminidase inhibitors: an update of the literature"],"prefix":"10.1080","volume":"25","author":[{"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sepulcri","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2385-1759","authenticated-orcid":false,"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Fusco","sequence":"additional","affiliation":[{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"},{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"Centers for Disease Control and Prevention (CDC). Key facts about influenza (Flu). [cited 2024 Jun 11]. Available from: https:\/\/www.cdc.gov\/flu\/about\/keyfacts.htm"},{"key":"e_1_3_4_4_1","unstructured":"WHO. Influenza (seasonal). [cited 2024 Jun 11]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)"},{"key":"e_1_3_4_5_1","unstructured":"WHO. Guidelines for the clinical management of severe illness from influenza virus infections. Geneva; 2022 [cited 2024 Jun 11]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK579105\/"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26990"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.01.005"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1110\/ps.41801"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq015"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050740"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05012-11"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2005.10.002"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270012440280"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00109"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy874"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70041-4"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy860"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx271"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12054"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62449-1"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2547"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-134"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.13.05.08026-en"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac217"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020963616"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0981-8"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350501000805"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2874"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00474-10"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00360-11"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.112"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1688"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01311-09"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01755-09"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/656802"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804958105"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.11.008"},{"issue":"2","key":"e_1_3_4_38_1","first-page":"44","article-title":"High levels of adamantane resistance among influenza a (H3N2) viruses and interim guidelines for use of antiviral agents \u2013 United States, 2005-06 influenza season","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","unstructured":"Centers for Disease Control and Prevention (CDC). High levels of adamantane resistance among influenza a (H3N2) viruses and interim guidelines for use of antiviral agents \u2013 United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep. 2006 Jan 20;55(2):44\u201346.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2019.01.006"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716197"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30004-9"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14249"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020273"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000532"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz656"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811345115"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.748"},{"key":"e_1_3_4_48_1","first-page":"Doc02","article-title":"Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations","volume":"9","author":"Duwe SC","year":"2021","unstructured":"Duwe SC, Schmidt B, Gartner BC, et al. Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations. GMS Infect Dis. 2021;9:Doc02.","journal-title":"GMS Infect Dis"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2128"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx013"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.06.004"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2475"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05529-11"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03840-9"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz100"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70717-0"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105281"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000498"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S105473"},{"key":"e_1_3_4_60_1","unstructured":"WHO Global Influenza Programme -Table 1. [cited 2024 Jun 11] Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/global-influenza-programme\/1.-nai_human_reduced-susceptibility-marker-table-(who)_07.03.23_update.pdf?sfvrsn=eef56b17_1&download=true"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00039"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/303041a0"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05026.x"},{"key":"e_1_3_4_64_1","unstructured":"Centers for Disease Control and Prevention (CDC). Influenza Antiviral Drug Resistance. [cited 2024 Jun 11]. Available from: https:\/\/www.cdc.gov\/flu\/treatment\/antiviralresistance.htm"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2067"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70318-8"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.04.009"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.05.003"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401492x"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113567"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112147"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01258"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104542"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19386-5"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11020237"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku074"},{"key":"e_1_3_4_77_1","unstructured":"Dose range study to evaluate the efficacy and safety of AV5080 in patients with influenza. [cited 2024 Jun 11]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05095545"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105499"},{"key":"e_1_3_4_79_1","unstructured":"A study of HNC042 in healthy Chinese subjects to evaluate the safety tolerability and pharmacokinetics (NCT04603989). [cited 2024 Jun 11]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04603989"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.08.047"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.34172\/jhp.2024.48132"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121480"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2370895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:54:39Z","timestamp":1727218479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2370895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,6,12]]}},"alternative-id":["10.1080\/14656566.2024.2370895"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2370895","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}